Valeo Financial Advisors’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$300K Buy
4,687
+35
+0.8% +$2.3K 0.01% 624
2026
Q1
$331K Sell
4,652
-2,068
-31% -$163K 0.01% 516
2025
Q4
$551K Sell
6,720
-1,272
-16% -$99.1K 0.01% 437
2025
Q3
$600K Sell
7,992
-2,908
-27% -$217K 0.01% 422
2025
Q2
$807K Buy
10,900
+3,303
+43% +$230K 0.02% 347
2025
Q1
$613K Sell
7,597
-71
-0.9% -$6.1K 0.02% 361
2024
Q4
$599K Buy
7,668
+544
+8% +$46.2K 0.02% 370
2024
Q3
$669K Sell
7,124
-10
-0.1% -$839 0.02% 341
2024
Q2
$556K Buy
7,134
+482
+7% +$39.3K 0.02% 363
2024
Q1
$577K Sell
6,652
-356
-5% -$29.6K 0.02% 334
2023
Q4
$542K Buy
7,008
+193
+3% +$13.5K 0.02% 337
2023
Q3
$464K Buy
6,815
+630
+10% +$45.8K 0.02% 353
2023
Q2
$502K Sell
6,185
-61
-1% -$4.87K 0.02% 321
2023
Q1
$512K Buy
+6,246
New +$446K 0.02% 329

Other funds holding GEHC

Valeo Financial Advisors's GEHC Position: Q2 2026 in Review

Valeo Financial Advisors increased its GE HealthCare (GEHC) stake by 0.75% in Q2 2026, buying an estimated $2.3K and bringing the position to 4,687 shares worth $300K. The position accounts for 0.01% of the portfolio, ranked #624.

Valeo Financial Advisors first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $807K in Q2 2025. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Valeo Financial Advisors held 4,687 shares of GE HealthCare worth $300K as of Q2 2026.
  • Valeo Financial Advisors bought 35 GE HealthCare shares in Q2 2026, an estimated $2.3K.
  • GE HealthCare made up 0.01% of Valeo Financial Advisors's portfolio in Q2 2026, its #624 holding.
  • Valeo Financial Advisors first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Valeo Financial Advisors's GE HealthCare position peaked at $807K in Q2 2025.
  • 1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Valeo Financial Advisors's 13F filing for Q2 2026, filed 8 Jul 2026.